Open AccessFertility preservation strategies for cancerous women: An updated review
Author(s) -
Fatemeh Anbari,
Mohammad Ali Khalili,
Maryam Mahaldashtian,
Alireza Ahmadi,
Maria Grazia Palmerini
Publication year - 2022
Publication title -
türk jinekoloji ve obstetrik derneði dergisi/türk jinekoloji ve obstetrik derneği dergisi
Language(s) - English
Resource type - Journals
eISSN - 1307-7007
pISSN - 1307-699X
DOI - 10.4274/tjod.galenos.2022.42272
Subject(s) - fertility preservation , cryopreservation , oocyte cryopreservation , premature ovarian insufficiency , infertility , ovarian tissue cryopreservation , fertility , embryo cryopreservation , medicine , gynecology , vitrification , live birth , in vitro maturation , pregnancy , andrology , premature ovarian failure , oocyte , biology , embryo , population , genetics , environmental health , microbiology and biotechnology
Due to the increase in cancer among young women, the risk of premature ovarian insufficiency with subsequent infertility has been raised. Fertility preservation restores reproductive potential along with increasing life expectancy in these patients. Given the articles on new options for treating cancerous women, we searched the keywords, including fertility preservation, in vitro maturation (IVM), and ovarian cryopreservation. This review focuses on the currently available procedures, including in (IVM) of retrieved immature oocytes, oocyte, embryo, and ovarian tissue cryopreservation (OTC). OTC is a helpful procedure that restores ovarian function and natural pregnancy. Also, we summarized the literature that reported the qualification of using the abovementioned procedures, comparing the cryopreservation methods including vitrification and slow freezing. Due to the impressive clinical development of OTC in cancerous patients, it is recommended as a standard treatment in cryopreservation strategies.